RARE ADULT SOLID CANCERS - ESOOESMOORCE CLINICAL UPDATE ON
←
→
Page content transcription
If your browser does not render page correctly, please read the page content below
Flyer Rare Tumours (12 May)_screen 12.05.2016 15:52 Pagina 3
ESO ADVANCED COURSES, SEMINARS AND SYMPOSIA
Held in collaboration with:
ESO-ESMO-RCE
CLINICAL UPDATE ON
RARE ADULT
SOLID CANCERS
25-27 November 2016
Milan, Italy
Chairs:
P.G. Casali, IT
R.A. Stahel, CH
Flyer Rare Tumours (12 May)_screen 12.05.2016 15:52 Pagina 4
INTRODUCTION
Rare cancers make up as many as one fifth of all new cancer cases. Amongst
them, pediatric cancers and rare hematologic neoplasms are often covered by
dedicated educational events, while adult solid rare cancers are hardly
grouped together and approached as a collective group of neoplasms.
Indeed, they account for as many as 15% of all new cancer cases, thus being
the main group within rare cancers. This Course is aimed at dealing with them
on an annual basis, to provide the community of clinical oncologists
specialising in these tumors with a regular update of recent advances in this
specific area. The ultimate goal is to strengthen the educational coverage of a
group of cancers which may be neglected in spite of their collective
incidence.
According to the RARECARE project, which provided a definition and a list of
rare cancers, rare adult solid cancers include the following big families of
tumors, each of them being therefore covered by a corresponding
educational session within this Course:
• Rare skin cancers and non-cutaneous melanoma
• Rare thoracic tumors
• Rare female genital cancers
• Neuroendocrine tumors
• Endocrine gland tumors
• Sarcomas
• Digestive rare cancers
• Rare urological and male genital tumors
• Central nervous system neoplasms
• Head and neck cancers
Any educational effort in the rare cancer area makes little sense if
disconnected from a networking environment. Thus, this Course will be first
offered to clinical oncologists involved into the existing networks covering
rare adult solid cancers, with a special attention to the new European
Reference Networks due to be created within the EU.
From the educational point of view, one cannot expect that even experienced
clinical oncologists are knowledgeable about all these tumors. For this reason,
the European Faculty of this Masterclass is asked to focus on the most recent
advances, always trying to put them into the context of state-of-the-art
treatment of these tumors, with a special view to ESMO Clinical Practice
Guidelines.
Flyer Rare Tumours (12 May)_screen 12.05.2016 15:52 Pagina 1
FACULTY (as of May)
S. Bielack, Klinikum Stuttgart Olgahospital, Stuttgart, DE
J.Y. Blay, Centre Léon Bérard, Lyon, FR
P.G. Casali, Fondazione IRCCS Istituto Nazionale Tumori, Milan, IT
F. de Braud, Fondazione IRCCS Istituto Nazionale Tumori, Milan, IT
F. De Lorenzo, European Cancer Patient Coalition, Brussels, BE
A.P. Dei Tos, Azienda ULSS9, Treviso, IT
R. Elisei, Medicina Clinica e Sperimentale, Università di Pisa, IT
N. Fazio, European Institute of Oncology, Milan, IT
S. Ferrari, Istituti Ortopedici Rizzoli, Bologna, IT
M. Garassino, Fondazione IRCCS Istituto Nazionale Tumori, Milan, IT
R. Glynne-Jones, Mount Vernon Hospital, Northwood , Middlesex, UK
V. Gregoire, Universitè Catholique, Louvain, BE
S. Grisanti, A.O. Spedali Civili, Brescia IT
L. Licitra, Fondazione IRCCS Istituto Nazionale Tumori, Milan, IT
D. Lorusso, Fondazione IRCCS Istituto Nazionale Tumori, Milan, IT
N. Nicolai, Fondazione IRCCS Istituto Nazionale Tumori, Milan, IT
K. Õberg, University Hospital, Uppsala, SE
G. Pravettoni, European Institute of Oncology, Milan, IT
I. Ray-Coquard, Centre Léon Bérard, Lyon, FR
M. Seckl, Hammersmith Campus, London, UK
C. Simon, Université de Lausanne, CHUV Lausanne, CH
R. Soffietti, AOU San Giovanni Battista, Torino, IT
R.A. Stahel, Clinic for Oncology, Zurich, CH
A. Trama, Fondazione IRCCS Istituto Nazionale Tumori, Milan, IT
D.C. Weber, Proton Therapy Center, Villigen, CHFlyer Rare Tumours (12 May)_screen 12.05.2016 15:52 Pagina 5
PROGRAMME
FRIDAY, 25 NOVEMBER
INTRODUCTION
11:00 Welcome from ESO and ESMO A. Costa, IT
R.A. Stahel, CH
11:15 Introduction P.G. Casali, IT
11:30 The epidemiology of rare cancers A. Trama, IT
11:45 The pathologic diagnosis in rare cancers A.P. Dei Tos, IT
12:00 Patient empowerment in rare cancers G. Pravettoni
12:15 The scenario of rare cancers in the EU F. De Lorenzo, BE
12:30 Discussion
13:00 Lunch
SESSION 1 RARE THORACIC CANCERS
14:00 Mesothelioma R.A. Stahel, CH
14:30 Thymic neoplasms M. Garassino, IT
15:00 Discussion
15:30 Coffee break
SESSION 2 NEUROENDOCRINE TUMORS
16:00 Thoracic neuroendocrine tumors N. Fazio, IT
16:30 Gastroenteropancreatic neuroendocrine tumors K. Oeberg, SE
17:00 Discussion
SESSION 3 ENDOCRINE GLAND TUMORS
17:30 Thyroid cancer R. Elisei, IT
18:00 Adrenal cancer S. Grisanti, IT
18:30 Discussion
SATURDAY, 26 NOVEMBER
SESSION 4 RARE FEMALE GENITAL TUMORS
8:00 Carcinoma of vagina and vulva D. Lorusso, IT
8:30 Rare ovarian cancers I. Ray-Coquard, FR
9:00 Trophoblastic tumors M. Seckl, UK
9:30 Discussion
10:00 Coffee break
SESSION 5 SARCOMAS
10:30 Adult soft tissue sarcomas P.G. Casali, IT
11:00 Gastrointestinal stromal tumors (GIST) J.Y. Blay, FRFlyer Rare Tumours (12 May)_screen 12.05.2016 15:52 Pagina 6
11:30 Ewing sarcoma S. Ferrari, IT
12:00 Osteosarcoma and other bone tumors S. Bielack, DE
12:30 Discussion
13:00 Lunch
SESSION 6 RARE UROLOGICAL AND MALE GENITAL
TUMORS
14:00 Testicular cancer N. Nicolai, IT
14:30 Rare urinary cancers F. de Braud, IT
15:00 Discussion
15:30 Coffee break
SESSION 7 RARE SKIN AND NON-CUTANEOUS MELANOMA
16:00 Skin adnexal tumors L. Licitra, IT
16:30 Uveal and mucosal melanoma D.C. Weber, CH
17:00 Discussion
SESSION 8 DIGESTIVE RARE CANCERS
17:30 Biliary tumors F. de Braud, IT
18:00 Anal carcinoma R. Glynne-Jones, UK
18:30 Discussion
SUNDAY, 27 NOVEMBER
SESSION 9 HEAD AND NECK CANCERS
8:30 Laryngeal and hypopharyngeal cancer C. Simon, CH
9:00 Oropharyngeal cancer V. Gregoire, BE
9:30 Nasopharyngeal cancer L. Licitra, IT
10:00 Oral cavity cancer C. Simon, CH
10:30 Salivary glands cancers L. Licitra, IT
11:00 Discussion
11:30 Coffee break
SESSION 10 CENTRAL NERVOUS SYSTEM TUMORS
12:00 Glioma R. Soffietti, IT
12:30 cPNET Speaker to be announced
13:00 Discussion
CLOSING REMARKS
13:30 Take home messages R.A. Stahel, CHFlyer Rare Tumours (12 May)_screen 12.05.2016 15:52 Pagina 7
GENERAL INFORMATION
ORGANISING SECRETARIAT
European School of Oncology
Rare Tumours Programme
c/o Fondazione IRCCS Istituto Nazionale dei Tumori
Via G. Venezian, 1
20133 Milano - Italy
Fax +39 0223902531 - www.eso.net
Email: raretumours@eso.net
VENUE
Swiss Chamber - Sala Meili
Via Palestro, 2
20121 Milano - Italy
Tel. +39 027632031
www.swisschamber.it
REGISTRATION
REGISTER ONLINE AT WWW.ESO.NET
Early Late
(by 30 September 2016) (from 1 October 2016)
Registration fee EUR 200
Club ESO Members EUR 150 EUR 250
ESMO Members EUR 150
Rates are quoted in Euro and include VAT.
Registration grants participation in all sessions, coffee breaks and lunches as
indicated in the programme.
TRAVEL GRANTS
Travel grants (registration, 2-night accommodation and travel expenses
contribution, up to the total amount of the grant) are made available on a
competitive basis thanks to the support of Rare Cancers Europe.
Priority will be given to younger candidates and low/middle income Countries.
Participants coming from:
• Italy EUR 650
• Southern and Western Europe EUR 850
• Northern, Central and Eastern Europe EUR 950
• Other and overseas EUR 1150
Applications should be submitted by 30 September 2016 to:
raretumours@eso.net
and include:
• Short curriculum vitae with full affiliation, contact details and date of birth;
• Letter describing motivation for attending.Flyer Rare Tumours (12 May)_screen 12.05.2016 15:52 Pagina 8
ACCREDITATION
Application for CME recognition will be submitted to Accreditation Council of
Oncology in Europe (ACOE), to the European Accreditation Council for
Continuing Medical Education (EACCME) and to the Italian CME accreditation
system. EACCME credits are recognised by the American Medical Association
towards the Physician’s Recognition Award (PRA).
Information on the status of the applications can be obtained from the
organising Secretariat.
CANCELLATION OF REGISTRATION OR REPLACEMENT
Cancellation should be notified to ESO in writing. In case of cancellation without
replacement, the fee, less handling charges of EUR 80, will be refunded after the
event, provided that the cancellation is received by ESO before 25 October.
Replacements will be possible till 25 October.
BADGE
The badge is the only official evidence of registration and should be worn at all
times during the event.
INSURANCE
The organisers bear no responsibility for untoward events in relation to the
participation in the Course. Participants are advised to take out their own
personal and travel insurance.
OFFICIAL LANGUAGE
The official language will be English. No translation will be provided.
IMPORTANT DEADLINES
Travel grants: 30 September 2016
Early registration: 30 September 2016
Late registration: from 1 October 2016Flyer Rare Tumours (12 May)_screen 12.05.2016 15:52 Pagina 2
REGISTRATION FORM
CLINICAL UPDATE ON RARE ADULT SOLID CANCERS, 25-27 November 2016, Milan, Italy
Please fill in this form in BLOCK CAPITALS and send by the deadline to:
European School of Oncology - Via Turati 29 - 20121 Milan - Italy
Fax: +39 02 85464545 - E mail: raretumours@eso.net
ONLINE REGISTRATION AT WWW.ESO.NET
PARTICIPANT'S DETAILS
Dr. Prof. Mrs. Mr.
Surname Name
Institute
Department
Street
Zip Code Town Country
Phone Fax Mobile
Email
Profession
Specialisation Main field
VAT number (compulsory for self-employed persons)
Fiscal code (Italian residents only)
If your invoice details are different to those above, please complete the following section:
Invoice contact person
Address
Phone email
VAT number (compulsory for self-employed persons)
Fiscal Code (Italian residents only)
REGISTRATION FEES:
Rates are quoted in Euro and include VAT.
Early Late
(by 30 September 2016) (from 1 October 2016)
Registration fee EUR 200 EUR 250
Club ESO Members EUR 150 EUR 250
ESMO Members EUR 150 EUR 250
PAYMENT DETAILS:
The registration is processed when payment accompanies the form (credit card details or copy of bank transfer)
Visa/Mastercard Card Number / / /
Expire date / CV2 code
Holder’s name: and signature
BANK TRANSFER with no cost to the beneficiary (please provide a copy of the bank transfer):
Bank: Banca Popolare di Milano, Agenzia 24 - Milan, Italy
Account holder: European School of Oncology
Number: No. 16333
IBAN: IT96G0558401624 0000000 16333 - BIC: BPMIITMMXXX
Reference: "Rare Tumours" + participant’s name
I authorize the European School of Oncology to use my personal data according to what is specified in Article 13
DLGS 196, available at www.eso.net or on request at fax number +39 02 8546 4545.
Signature DateYou can also read
